Cetera Advisor Networks LLC Exact Sciences Corp Transaction History

Cetera Advisor Networks LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $137,073 - $179,703	-2,436 Reduced 4.8%	48,309 $3.34 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $519,432 - $665,957	8,795 Added 20.97%	50,745 $3.75 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $508,990 - $764,489	7,719 Added 22.55%	41,950 $2.86 Million
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $69,449 - $105,315	1,108 Added 3.35%	34,231 $3.21 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $47,142 - $70,699	-999 Reduced 2.93%	33,123 $2.25 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $703,937 - $1.23 Million	23,194 Added 212.24%	34,122 $1.69 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $9,303 - $14,366	291 Added 2.74%	10,928 $355,000
Q2 2022 Aug 11, 2022	BUY	$35.61 - $76.23 $33,402 - $71,503	938 Added 9.67%	10,637 $419,000
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $9,785 - $14,031	170 Added 1.78%	9,699 $678,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $291,667 - $405,035	4,023 Added 73.07%	9,529 $742,000
Q3 2021 Nov 16, 2021	SELL	$90.24 - $124.05 $43,405 - $59,668	-481 Reduced 8.03%	5,506 $526,000
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $313,105 - $465,579	3,343 Added 126.44%	5,987 $744,000
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $5,362 - $7,130	46 Added 1.77%	2,644 $348,000
Q4 2020 Feb 17, 2021	BUY	$99.61 - $142.12 $258,786 - $369,227	2,598 New	2,598 $344,000
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $170,705 - $238,805	-2,341 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $130,510 - $217,127	2,341 New	2,341 $204,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.